QXO Completes TopBuild, Market Sells the News; Integration Execution Now Key

What happened

QXO has closed its $17B acquisition of TopBuild, creating an $18B revenue platform with extensive national reach. Despite this milestone, the stock sold off, reflecting the market's focus on the significant integration challenges ahead and the company's weak current profitability. Q1'26 results showed just $1.2M in Adjusted EBITDA on $1.73B in revenue, underscoring that cost synergies and operational leverage are far from realized. Management targets $4B organic EBITDA by 2030, but the path requires compressing restructuring/transformation costs that totaled $46.9M in Q1 alone. The deal's completion removes a key overhang, but now the investment case hinges on observable cost takeout and margin improvement in the coming quarters.

Implication

The completion of TopBuild eliminates a major break-risk catalyst, shifting focus to execution. Near-term, the stock may face headwinds from integration costs and heavy preferred dividends. However, the current price (~$18) is below the deal's acquisition value, offering an attractive entry for patient investors. Over 12-18 months, if management delivers on the planned cost synergies and SG&A compression, the stock could re-rate substantially. Key milestones include the Q3'26 10-Q showing Kodiak purchase accounting and a decline in restructuring costs. Failure to show progress by mid-2027 could lead to value erosion and a re-test of $16 or lower.

Thesis delta

The thesis shifts from deal uncertainty to operating execution. The 6-9 month focus moves from closing risk to whether integration costs fade and SG&A falls from 28.7% of sales. The WAIT rating from the DeepValue report remains appropriate until visible cost compression emerges, likely after the next two quarterly filings.